Literature DB >> 31001812

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study.

M Papini, F Cusano, M Romanelli, M Burlando, G Stinco, G Girolomoni, K Peris, C Potenza, A Offidani, M Bartezaghi, E Aloisi, A Costanzo.   

Abstract

Entities:  

Year:  2019        PMID： 31001812     DOI： 10.1111/bjd.18013

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  6 in total

1.  Psoriasis Patients with Specific HLA-Cw Alleles and Lower Plasma IL-17 Level Show Improved Response to Topical Lindioil Treatment.

Authors:  Chuang-Wei Wang; Rosaline Chung-Yee Hui; Wen-Hung Chung; Yin-Ku Lin; Ching-Ya Wang; Yu-Huei Huang; Ya-Ching Chang; Chun-Bing Chen
Journal:  Pharmgenomics Pers Med       Date:  2022-05-13

2.  Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study.

Authors:  Antonio Costanzo; Filomena Russo; Marco Galluzzo; Luca Stingeni; Roberta Scuderi; Leonardo Zichichi; Manuela Papini; Luisa Di Costanzo; Andrea Conti; Martina Burlando; Andrea Chiricozzi; Francesca Maria Gaiani; Cristina Mugheddu; Maria Letizia Musumeci; Paolo Gisondi; Stefano Piaserico; Paolo Dapavo; Marina Venturini; Gianluca Pagnanelli; Paolo Amerio; Concetta Potenza; Ketty Peris; Franca Cantoresi; Sara Trevisini; Francesco Loconsole; Annamaria Offidani; Santo Raffaele Mercuri; Viviana Lora; Francesca Prignano; Marta Bartezaghi; Giovanni Oliva; Elisabetta Aloisi; Roberto Orsenigo
Journal:  Acta Derm Venereol       Date:  2021-10-21       Impact factor: 3.875

3.  Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.

Authors:  Marina Talamonti; Giovanna Malara; Ylenia Natalini; Federico Bardazzi; Andrea Conti; Andrea Chiricozzi; Cristina Mugheddu; Paolo Gisondi; Stefano Piaserico; Gianluca Pagnanelli; Paolo Amerio; Concetta Potenza; Franca Cantoresi; Maria Concetta Fargnoli; Anna Balato; Francesco Loconsole; Annamaria Offidani; Claudio Bonifati; Francesca Prignano; Marta Bartezaghi; Alice Rausa; Elisabetta Aloisi; Roberto Orsenigo; Antonio Costanzo
Journal:  Acta Derm Venereol       Date:  2021-03-31       Impact factor: 3.875

Review 4.  Pharmacogenetics Update on Biologic Therapy in Psoriasis.

Authors:  Ester Muñoz-Aceituno; Luisa Martos-Cabrera; María Carmen Ovejero-Benito; Alejandra Reolid; Francisco Abad-Santos; Esteban Daudén
Journal:  Medicina (Kaunas)       Date:  2020-12-20       Impact factor: 2.430

5.  Comparison of Efficacy of Anti-interleukin-17 in the Treatment of Psoriasis Between Caucasians and Asians: A Systematic Review and Meta-Analysis.

Authors:  Danyi Zhang; Jianing Qiu; Xing Liao; Yi Xiao; Minxue Shen; Yaxiong Deng; Danrong Jing
Journal:  Front Med (Lausanne)       Date:  2022-01-25

Review 6.  Towards Personalized Medicine in Psoriasis: Current Progress.

Authors:  Elisa Camela; Luca Potestio; Angelo Ruggiero; Sonia Sofia Ocampo-Garza; Gabriella Fabbrocini; Matteo Megna
Journal:  Psoriasis (Auckl)       Date:  2022-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.